Registry of Vaccine Responses in Immune Compromised Patients
Recruiting
Observational Study
Immunosuppression
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Laure Pittet, MD-PhD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this project is to monitor, guide and document vaccination, vaccine responses, persistence of protection, vaccine efficacy and safety in immune compromised patients at various moment of their disease: right after the diagnosis, before the introduction of the immunosuppressive treatment, once the individual is under immunosuppressive treatment, or once immunosuppression is over.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Immune compromised patient or patient who will soon be immunocompromised
2. Informed consent as documented by signature
Exclusion Criteria:
1. Individual/parental inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, known/…
Contacts